U.S. flag

An official website of the United States government

NM_183050.4(BCKDHB):c.25G>A (p.Gly9Ser) AND not provided

Germline classification:
Uncertain significance (1 submission)
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001357758.1

Allele description [Variation Report for NM_183050.4(BCKDHB):c.25G>A (p.Gly9Ser)]

NM_183050.4(BCKDHB):c.25G>A (p.Gly9Ser)

Gene:
BCKDHB:branched chain keto acid dehydrogenase E1 subunit beta [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
6q14.1
Genomic location:
Preferred name:
NM_183050.4(BCKDHB):c.25G>A (p.Gly9Ser)
HGVS:
  • NC_000006.12:g.80106718G>A
  • NG_009775.2:g.5092G>A
  • NM_000056.5:c.25G>A
  • NM_001318975.1:c.-15+35G>A
  • NM_183050.4:c.25G>AMANE SELECT
  • NP_000047.1:p.Gly9Ser
  • NP_898871.1:p.Gly9Ser
  • NC_000006.11:g.80816435G>A
  • NG_009775.1:g.5092G>A
  • NR_134945.2:n.48G>A
Protein change:
G9S
Links:
dbSNP: rs571728255
NCBI 1000 Genomes Browser:
rs571728255
Molecular consequence:
  • NM_001318975.1:c.-15+35G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000056.5:c.25G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_183050.4:c.25G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_134945.2:n.48G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001553322Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR)

See additional submitters

no assertion criteria provided
Uncertain significanceunknownclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR), SCV001553322.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The BCKDHB p.G9S variant was not identified in the literature nor was it identified in ClinVar. The variant was identified in dbSNP (ID: rs571728255) and in control databases in 42 of 148688 chromosomes (1 homozygous) at a frequency of 0.0002825, and was observed only in the South Asian population in 42 of 23324 chromosomes (1 homozygous) (freq: 0.001801) (Genome Aggregation Database March 6, 2019, v2.1.1). The p.G9 residue is conserved in mammals and computational analyses (MUT Assesor, SIFT, MutationTaster, Revel, FATHMM, MetaLR, DANN) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (Splice AI exome) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 6, 2024